NO932096L - Fosfinyloksy-propanaminium-derivater - Google Patents

Fosfinyloksy-propanaminium-derivater

Info

Publication number
NO932096L
NO932096L NO932096A NO932096A NO932096L NO 932096 L NO932096 L NO 932096L NO 932096 A NO932096 A NO 932096A NO 932096 A NO932096 A NO 932096A NO 932096 L NO932096 L NO 932096L
Authority
NO
Norway
Prior art keywords
fosfinyloksy
propanaminium
derivatives
thiolysis
thiolation
Prior art date
Application number
NO932096A
Other languages
English (en)
Norwegian (no)
Other versions
NO932096D0 (no
Inventor
Robert Charles Anderson
Gregory Raymond Bebernitz
James Donald Fraser
Jeffery Wayne Hughes
Prasad Koteswara Kapa
Mahavir Prashad
Howard Charles Smith
Edwin Bernard Villhauer
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO932096D0 publication Critical patent/NO932096D0/no
Publication of NO932096L publication Critical patent/NO932096L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • C07F9/1651Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/113Esters of phosphoric acids with unsaturated acyclic alcohols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO932096A 1992-06-11 1993-06-09 Fosfinyloksy-propanaminium-derivater NO932096L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89721092A 1992-06-11 1992-06-11

Publications (2)

Publication Number Publication Date
NO932096D0 NO932096D0 (no) 1993-06-09
NO932096L true NO932096L (no) 1993-12-13

Family

ID=25407534

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932096A NO932096L (no) 1992-06-11 1993-06-09 Fosfinyloksy-propanaminium-derivater

Country Status (21)

Country Link
EP (1) EP0574355B1 (es)
JP (1) JPH0673077A (es)
KR (1) KR940005647A (es)
CN (1) CN1039326C (es)
AT (1) ATE156828T1 (es)
AU (1) AU667537B2 (es)
CA (1) CA2098133A1 (es)
CZ (1) CZ108393A3 (es)
DE (1) DE69313029T2 (es)
DK (1) DK0574355T3 (es)
ES (1) ES2105194T3 (es)
FI (1) FI932662A (es)
GR (1) GR3024684T3 (es)
HU (2) HUT65327A (es)
IL (1) IL105965A (es)
MY (1) MY109005A (es)
NO (1) NO932096L (es)
NZ (1) NZ247840A (es)
SG (1) SG42983A1 (es)
SK (1) SK58893A3 (es)
ZA (1) ZA934157B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
WO2004074298A1 (ja) * 2003-02-18 2004-09-02 Tokai University ホスホリルコリン基を有する化合物、その重合体ならびにその製造方法
US20090312286A1 (en) 2006-08-02 2009-12-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
CN114364385A (zh) 2019-08-30 2022-04-15 中国科学院动物研究所 用于对抗代谢疾病的组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348859A1 (en) * 1988-07-01 1990-01-03 MAGIS FARMACEUTICI S.p.A. 1,2-di-O-acyl glycero(DI)phosphate of L-carnitine and its derivatives, a process for their preparation and pharmaceutical formulations which contain them
IT1231751B (it) * 1989-04-12 1991-12-21 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT1230141B (it) * 1989-05-03 1991-10-14 Fidia Spa Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
IT1230142B (it) * 1989-05-03 1991-10-14 Fidia Spa Derivati della carnitina, processo per la loro preparazione e impiego in terapia umana

Also Published As

Publication number Publication date
NZ247840A (en) 1995-04-27
SK58893A3 (en) 1994-06-08
FI932662A0 (fi) 1993-06-10
DK0574355T3 (da) 1998-01-26
HUT65327A (en) 1994-05-02
CZ108393A3 (en) 1995-02-15
CN1039326C (zh) 1998-07-29
KR940005647A (ko) 1994-03-22
FI932662A (fi) 1993-12-12
DE69313029T2 (de) 1998-01-29
AU667537B2 (en) 1996-03-28
EP0574355A1 (en) 1993-12-15
CN1086217A (zh) 1994-05-04
ATE156828T1 (de) 1997-08-15
MY109005A (en) 1996-11-30
HU9301587D0 (en) 1993-09-28
CA2098133A1 (en) 1993-12-12
DE69313029D1 (de) 1997-09-18
IL105965A (en) 1997-03-18
ZA934157B (en) 1994-09-05
GR3024684T3 (en) 1997-12-31
IL105965A0 (en) 1993-10-20
SG42983A1 (en) 1997-10-17
HU211489A9 (en) 1995-11-28
AU4011593A (en) 1993-12-16
NO932096D0 (no) 1993-06-09
JPH0673077A (ja) 1994-03-15
EP0574355B1 (en) 1997-08-13
ES2105194T3 (es) 1997-10-16

Similar Documents

Publication Publication Date Title
AU1282495A (en) Anthranilic acid derivative
ES552722A0 (es) Un procedimiento para preparar un complejo liposoluble de platino divalente.
CA2011087A1 (en) Use of trifluoromethylphenylazolylmethyloxiranes as crop protection agents
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
ES2132135T3 (es) Procedimiento para la preparacion de compuestos de tiazolidina u oxazolidina farmaceuticamente activos mediante una reductasa de levadura.
AU7659687A (en) Sulphonamide containing phenoxyacetic acid derivatives and their preparation
AU8491691A (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
DK0574355T3 (da) Phosphinyloxypropanaminium-indre saltderivater
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
ATE236162T1 (de) Pyrroloazepinderivate
AU1406888A (en) Biologically active compounds
DE69511449D1 (de) Octahydro-2-Naphthalincarbonsäure-Derivate, ihre Herstellung und Verwendung
ATE158585T1 (de) Substituierte bizyklische oxazol- und thiazol- äther